The pandemic has shaped the future of remote healthcare as the importance of providing access to essential healthcare services grew dramatically as the world scrambled to move to digital. In fact, 23.6% of all healthcare interactions were via telehealth during the first four months of the pandemic, up from just .3% for the same period in 2019. Ro, founded in 2017, is one of the pioneering patient-driven telehealth companies that’s built to be the first point of contact when you need to see a physician. The technology allows you to seamlessly connect with a physician, nurse, or pharmacist in minutes instead of days or weeks, bringing the care experience online instead of at a doctor’s office. Ro also operates its own pharmacy fulfillment business, effectively allowing the company to support patient needs from the initial diagnosis to treatment/delivery and everything in between. Structured as a holding company that’s able to capitalize on a robust centralized platform, Ro operates a growing family of brands that redefine how we approach healthcare. Among them are Roman (digital health clinic for men), Rory (digital health for women), Zero (smoking cessation), Ro Pharmacy, Plenity (weight management), and Workpath (API to power on-demand, in-home healthcare). It’s safe to assume that the massive shift towards telehealth has provided Ro with valuable data on patient preferences that will fuel the company’s future verticals and next phase of expansion, armed with this latest round of funding.